An optimized PanFlu-IOA-based mRNA vaccine targeting hemagglutinin confers broad-spectrum protection against heterosubtypic influenza viruses in mice

The rapid mutation rate of influenza viruses necessitates annual updates of vaccine formulations, underscoring the urgent need for a universal influenza vaccine. Current computationally optimized antigen strategies are mostly confined to certain subtypes and thus fail to elicit broad-spectrum immunity against heterosubtypic strains. Here, we developed the PanFlu-IOA (Pan-Influenza Iteratively Optimized Antigen) toolkit to overcome systemic bias and extract universal antigenic features across diverse evolutionary branches. Using this toolkit, we generated two universal hemagglutinin (HA) sequences G1-HA and G2-HA for influenza virus Group 1 and Group 2, respectively. These two HAs were incorporated into an mRNA-lipid nanoparticle system to construct a broad-spectrum vaccine candidate termed panFluA. In mice, panFluA elicits robust cross-reactive humoral immunity, Th1-biased systemic CD4⁺ T cell responses, and cytotoxic CD8⁺ T cell activation, while successfully establishing durable lung-resident memory T cells. Notably, panFluA conferred potent cross-protection against lethal challenges with highly divergent Group 1 and Group 2 influenza viruses. Mechanistic studies revealed that this protection was mediated by the coordinated action of humoral and cellular immunity, as confirmed by T-cell depletion and passive serum transfer experiments. Overall, panFluA induced broad immune responses against conserved HA antigens. Our study provides a general strategy for next-generation universal influlenza vaccines. Researchers developed PanFlu-IOA, a computational approach to design a broad spectrum mRNA influenza vaccine. The vaccine induced broad immune responses and protected mice against multiple influenza subtypes, offering a path to universal vaccines.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-15
DOI
https://doi.org/10.1038/s41467-026-79813-x
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An optimized PanFlu-IOA-based mRNA vaccine targeting hemagglutinin confers broad-spectrum protection against heterosubtypic influenza viruses in mice

Yang Xi, Man Xing, Weiqian Dai, Shulei Jia et al.
Nature Communications
Influenza Virus Research Studies
article

An optimized PanFlu-IOA-based mRNA vaccine targeting hemagglutinin confers broad-spectrum protection against heterosubtypic influenza viruses in mice

Yang Xi, Man Xing, Weiqian Dai, Shulei Jia, Dongming Zhou, Ping Zhou, Yao Yan, Xiang Wang, Caihong Zhu, Hongyang Shi, Wenying Zhao, Ying Li
article en

Abstract

The rapid mutation rate of influenza viruses necessitates annual updates of vaccine formulations, underscoring the urgent need for a universal influenza vaccine. Current computationally optimized antigen strategies are mostly confined to certain subtypes and thus fail to elicit broad-spectrum immunity against heterosubtypic strains. Here, we developed the PanFlu-IOA (Pan-Influenza Iteratively Optimized Antigen) toolkit to overcome systemic bias and extract universal antigenic features across diverse evolutionary branches. Using this toolkit, we generated two universal hemagglutinin (HA) sequences G1-HA and G2-HA for influenza virus Group 1 and Group 2, respectively. These two HAs were incorporated into an mRNA-lipid nanoparticle system to construct a broad-spectrum vaccine candidate termed panFluA. In mice, panFluA elicits robust cross-reactive humoral immunity, Th1-biased systemic CD4⁺ T cell responses, and cytotoxic CD8⁺ T cell activation, while successfully establishing durable lung-resident memory T cells. Notably, panFluA conferred potent cross-protection against lethal challenges with highly divergent Group 1 and Group 2 influenza viruses. Mechanistic studies revealed that this protection was mediated by the coordinated action of humoral and cellular immunity, as confirmed by T-cell depletion and passive serum transfer experiments. Overall, panFluA induced broad immune responses against conserved HA antigens. Our study provides a general strategy for next-generation universal influlenza vaccines. Researchers developed PanFlu-IOA, a computational approach to design a broad spectrum mRNA influenza vaccine. The vaccine induced broad immune responses and protected mice against multiple influenza subtypes, offering a path to universal vaccines.

Nature Communications
Fudan University (CN), Shanghai Public Health Clinical Center (CN), Tianjin Medical University (CN)
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon